Leave message
Can’t find what you’re looking for?
Fill out this form to inquire about our custom protein services!
Inquire about our Custom Services >>
| Cat. No. | Species | Product Description | Structure | Purity | Feature |
|---|---|---|---|---|---|
| IF1-H5223 | Human | Human IFN-gamma R1 / IFNGR1 Protein, His Tag |  |
|
|
| IF1-H5254 | Human | Human IFN-gamma R1 / IFNGR1 Protein, Fc Tag |  |
|
|
Immobilized Human IFN-gamma, premium grade (Cat. No. IFG-H4211) at 5 μg/mL (100 μL/well) can bind Human IFN-gamma R1, Fc Tag (Cat. No. IF1-H5254) with a linear range of 0.1-6 ng/mL (QC tested).
| Name | Research Code | Research Phase | Company | First Brand Name | First Approved Country | First Indication | First Approved Company | First Approved Date | Indications | Clinical Trials |
|---|---|---|---|---|---|---|---|---|---|---|
| Interferon gamma biosimilar (Livzon Pharmaceutical Group) | Approved | Livzon Pharmaceutical Group Inc | Mainland China | Arthritis, Rheumatoid | Livzon Pharmaceutical Group Inc | 1998-01-01 | Arthritis, Rheumatoid | Details | ||
| Interferon gamma (Hayashibara) | OH-6000 | Approved | Hayashibara | Ogamma | Japan | Skin Neoplasms | null | 1997-08-05 | Skin Neoplasms | Details |
| Recombinant interferon gamma (Shanghai Chemo Wanbang Biopharma) | Approved | Shanghai Chemo Wanbang Biophama Co Ltd | 伽玛, gamma | Mainland China | Arthritis, Rheumatoid; Liver Cirrhosis | Shanghai Chemo Wanbang Biophama Co Ltd | 1998-01-01 | Arthritis, Rheumatoid; Liver Cirrhosis; Granulomatous Disease, Chronic | Details | |
| Interferon gamma-1a biosimilar (Shionogi) | S-6810 | Approved | Shionogi & Co Ltd | Imunomax-γ | Japan | Mycosis Fungoides; Carcinoma, Renal Cell; Myocardial Infarction; Communicable Diseases | Shionogi & Co Ltd | 1989-09-29 | Carcinoma, Renal Cell; Myocardial Infarction; Communicable Diseases; Mycosis Fungoides | Details |
| Interferon gamma-1b | DasKloster-1001; DasKloster-1001-01; AMG-292 | Approved | Genentech Inc | Imukin 1, Actimmune, Immukin | United States | Osteopetrosis; Granulomatous Disease, Chronic | Horizon Therapeutics Ireland Dac | 1999-02-25 | Candidemia; Melanoma; Mycobacterium avium-intracellulare Infection; Macular Degeneration; Plaque psoriasis; Hepatitis C, Chronic; Uveitis; Retinal Degeneration; Adenocarcinoma, Mucinous; Leukemia, Myeloid, Acute; Granulomatous Disease, Chronic; Uveitis, Anterior; Pulmonary Aspergillosis; Tuberculosis, Pulmonary; Osteopetrosis; HIV Infections; Friedreich Ataxia; Aspergillosis; Pulmonary Fibrosis; Lung Diseases; Retinal Diseases; Liver Cirrhosis; Colonic Neoplasms; Myelodysplastic Syndromes; Idiopathic Pulmonary Fibrosis; Eye Diseases, Hereditary; Pneumonia; Rectal Neoplasms; Cystic Fibrosis | Details |
| Interferon biosimilar (LG Life Sciences) | Approved | Lg Chemical Ltd | Leukemia | Lg Chemical Ltd | 1989-01-01 | Leukemia | Details | |||
| Interferon gamma-1a (Asubio Pharma) | SUN-4800 | Approved | Asubio | Biogamma | Japan | Mycosis Fungoides | Asubio | 1992-01-01 | Mycosis Fungoides | Details |
| Interferon gamma biosimilar (Pharmaclon) | Approved | Pharmaclon | Ingaron | Russian Federation | Tuberculosis, Pulmonary; Influenza, Human; HIV Infections; Hepatitis B; Herpes Zoster; Warts; Hepatitis C; Chlamydia Infections; Neoplasms; Respiratory Distress Syndrome, Newborn; Prostatitis | Pharmaclon | 2011-01-01 | HIV Infections; RNA Virus Infections; Warts; Papillomavirus Infections; Neoplasms; Tuberculosis, Pulmonary; Influenza, Human; Hepatitis B; Chlamydia Infections; Hepatitis C; Prostatitis; Herpes Zoster; Lentivirus Infections; Condylomata Acuminata; Respiratory Distress Syndrome, Newborn | Details | |
| Interferon Gamma (Materia Medica Holding) | Approved | Materia Medica Holding Research And Production Company | Anaferon | Virus Diseases; Bacterial Infections | Details | |||||
| Interferon gamma biosimilar (Center for Genetic Engineering and Biotechnology) | Approved | Center For Genetic Engineering And Biotechnology | Idiopathic Pulmonary Fibrosis; Tuberculosis | Details | ||||||
| Interferon gamma biosimilar (Recpharma) | Approved | Recpharma | IMMUNEX | Osteoporosis; Virus Diseases; Neoplasms; Granulomatous Disease, Chronic | Details |
| Name | Research Code | Research Phase | Company | Indications | Clinical Trials |
|---|---|---|---|---|---|
| rSIFN-co | Phase 3 Clinical | Sichuan Huiyang Life Science and Technology Corp | Carcinoma, Renal Cell; Hepatitis B, Chronic; Coronavirus Disease 2019 (COVID-19); Colonic Neoplasms; Neuroendocrine Tumors; Prostatic Neoplasms; Colorectal Neoplasms; Lung Neoplasms; Melanoma; Carcinoma, Non-Small-Cell Lung; Carcinoma, Hepatocellular | Details | |
| Interferon gamma (aerosol, IPF/ COPD), Stony Brook University School of Medicine | Phase 2 Clinical | Nostrum, Stony Brook University School Of Medicine, Nyu Langone Medical Center | Pulmonary Disease, Chronic Obstructive | Details |
This web search service is supported by Google Inc.
A-Z
